Medical Research and Clinical Trials

Unmasking the Paradox: Breakthrough Study Reveals Dual Nature of Immune Cells in Colorectal Cancer, Paving Way for Targeted Therapies

• Medical Research and Clinical Trials

Unmasking the Paradox: Breakthrough Study Reveals Dual Nature of Immune Cells in Colorectal Cancer, Paving Way for Targeted Therapies

Basiran July 12, 2026

New York, NY – For decades, a perplexing paradox has confounded cancer researchers: while an abundance of...

Read More Read more about Unmasking the Paradox: Breakthrough Study Reveals Dual Nature of Immune Cells in Colorectal Cancer, Paving Way for Targeted Therapies

Rethinking Menopause: New Study Unveils Potential Long-Term Cardiovascular Benefits of Hormone Therapy

• Medical Research and Clinical Trials

Rethinking Menopause: New Study Unveils Potential Long-Term Cardiovascular Benefits of Hormone Therapy

Nila Kartika Wati July 12, 2026

The enduring debate surrounding hormone therapy (HT) during menopause has long been fraught with complexities, balancing the...

Read More Read more about Rethinking Menopause: New Study Unveils Potential Long-Term Cardiovascular Benefits of Hormone Therapy

Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

• Medical Research and Clinical Trials

Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Lina Irawan July 12, 2026

LONDON & NEW YORK – In a significant stride forward for cancer research, an international consortium of...

Read More Read more about Groundbreaking Research Reveals Age-Related Blood Cell Mutations Infiltrate Tumours, Worsening Cancer Outcomes

Decades-Old Protein, New Cancer Foe: Unveiling Erythropoietin’s Surprising Role in Immune Evasion

• Medical Research and Clinical Trials

Decades-Old Protein, New Cancer Foe: Unveiling Erythropoietin’s Surprising Role in Immune Evasion

Reynand Wu July 11, 2026

Stanford University scientists have uncovered a groundbreaking, dual identity for erythropoietin (EPO), a protein long celebrated for...

Read More Read more about Decades-Old Protein, New Cancer Foe: Unveiling Erythropoietin’s Surprising Role in Immune Evasion

Breakthrough Research Offers Hope for Breast Cancer Prevention, Tackling Metabolic Risks in Menopausal Women

• Medical Research and Clinical Trials

Breakthrough Research Offers Hope for Breast Cancer Prevention, Tackling Metabolic Risks in Menopausal Women

Sagoh July 11, 2026

WASHINGTON D.C. – A significant proportion of women in the United States, approximately one-quarter of those between...

Read More Read more about Breakthrough Research Offers Hope for Breast Cancer Prevention, Tackling Metabolic Risks in Menopausal Women

AI’s Visionary Leap: UCLA Study Illuminates Path to Earlier Breast Cancer Detection

• Medical Research and Clinical Trials

AI’s Visionary Leap: UCLA Study Illuminates Path to Earlier Breast Cancer Detection

Ammar Sabilarrohman July 11, 2026

LOS ANGELES, CA – A groundbreaking study spearheaded by investigators at the UCLA Health Jonsson Comprehensive Cancer...

Read More Read more about AI’s Visionary Leap: UCLA Study Illuminates Path to Earlier Breast Cancer Detection

AI’s Collaborative Future in Breast Cancer Screening: A New Paradigm for Diagnostics

• Medical Research and Clinical Trials

AI’s Collaborative Future in Breast Cancer Screening: A New Paradigm for Diagnostics

Nila Kartika Wati July 11, 2026

URBANA-CHAMPAIGN, IL – The burgeoning power of artificial intelligence (AI) is poised to revolutionize countless sectors, and...

Read More Read more about AI’s Collaborative Future in Breast Cancer Screening: A New Paradigm for Diagnostics

Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Dramatically Boosts Survival for BRCA1/2 Breast Cancer Patients

• Medical Research and Clinical Trials

Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Dramatically Boosts Survival for BRCA1/2 Breast Cancer Patients

Ali Ikhwan July 10, 2026

Cambridge, UK – A groundbreaking study spearheaded by researchers at the University of Cambridge has delivered a...

Read More Read more about Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Dramatically Boosts Survival for BRCA1/2 Breast Cancer Patients

Salk Institute Uncovers Key to Revitalizing Cellular Energy: Estrogen-Related Receptors Offer New Hope for Metabolic Disorders

• Medical Research and Clinical Trials

Salk Institute Uncovers Key to Revitalizing Cellular Energy: Estrogen-Related Receptors Offer New Hope for Metabolic Disorders

Laily UPN July 10, 2026

LA JOLLA, CA – May 12, 2025 – A groundbreaking study from the Salk Institute, published today...

Read More Read more about Salk Institute Uncovers Key to Revitalizing Cellular Energy: Estrogen-Related Receptors Offer New Hope for Metabolic Disorders

Cambridge Breakthrough Heralds New Era for Inherited Breast Cancer Treatment: 100% Survival Achieved in Groundbreaking Trial

• Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Inherited Breast Cancer Treatment: 100% Survival Achieved in Groundbreaking Trial

Nana Wu July 10, 2026

Cambridge, UK – A revolutionary treatment approach developed by researchers at the University of Cambridge and Addenbrooke’s...

Read More Read more about Cambridge Breakthrough Heralds New Era for Inherited Breast Cancer Treatment: 100% Survival Achieved in Groundbreaking Trial